PRINCETON N.J. Dec. 28 2012 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a development stage biopharmaceutical company announced today that it has recently received approximately $521000 net of transaction costs in nondilutive fin...
↧